These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 11398948)

  • 1. Perioperative management protocols for children with moyamoya disease.
    Nomura S; Kashiwagi S; Uetsuka S; Uchida T; Kubota H; Ito H
    Childs Nerv Syst; 2001 Apr; 17(4-5):270-4. PubMed ID: 11398948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postoperative Cerebral Infarction Risk Factors and Postoperative Management of Pediatric Patients with Moyamoya Disease.
    Muraoka S; Araki Y; Kondo G; Kurimoto M; Shiba Y; Uda K; Ota S; Okamoto S; Wakabayashi T
    World Neurosurg; 2018 May; 113():e190-e199. PubMed ID: 29432946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perioperative factors related to the development of ischemic complications in patients with moyamoya disease.
    Sato K; Shirane R; Yoshimoto T
    Childs Nerv Syst; 1997 Feb; 13(2):68-72. PubMed ID: 9105739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relevance of hemodynamic factors to perioperative ischemic complications in childhood moyamoya disease.
    Iwama T; Hashimoto N; Yonekawa Y
    Neurosurgery; 1996 Jun; 38(6):1120-5; discussion 1125-6. PubMed ID: 8727141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pial synangiosis in patients with moyamoya syndrome and sickle cell anemia: perioperative management and surgical outcome.
    Smith ER; McClain CD; Heeney M; Scott RM
    Neurosurg Focus; 2009 Apr; 26(4):E10. PubMed ID: 19335126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term follow-up of pediatric moyamoya disease treated by combined direct-indirect revascularization surgery: single institute experience with surgical and perioperative management.
    Rashad S; Fujimura M; Niizuma K; Endo H; Tominaga T
    Neurosurg Rev; 2016 Oct; 39(4):615-23. PubMed ID: 27180559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for postoperative ischemic complications in patients with moyamoya disease.
    Kim SH; Choi JU; Yang KH; Kim TG; Kim DS
    J Neurosurg; 2005 Nov; 103(5 Suppl):433-8. PubMed ID: 16302615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postoperative neurological deterioration in pediatric moyamoya disease: watershed shift and hyperperfusion.
    Hayashi T; Shirane R; Fujimura M; Tominaga T
    J Neurosurg Pediatr; 2010 Jul; 6(1):73-81. PubMed ID: 20593991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unstable moyamoya disease: clinical features and impact on perioperative ischemic complications.
    Funaki T; Takahashi JC; Takagi Y; Kikuchi T; Yoshida K; Mitsuhara T; Kataoka H; Okada T; Fushimi Y; Miyamoto S
    J Neurosurg; 2015 Feb; 122(2):400-7. PubMed ID: 25423271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perioperative complications of encephalo-duro-arterio-synangiosis: prevention and treatment.
    Matsushima Y; Aoyagi M; Suzuki R; Tabata H; Ohno K
    Surg Neurol; 1991 Nov; 36(5):343-53. PubMed ID: 1745958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk Factors for Newly Developed Cerebral Infarction After Surgical Revascularization for Adults with Moyamoya Disease.
    Park W; Ahn JS; Lee HS; Park JC; Kwun BD
    World Neurosurg; 2016 Aug; 92():65-73. PubMed ID: 27020972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Preventing Crying after Revascularization Surgery in Pediatric Patients with Moyamoya Disease:Sedation with Dexmedetomidine].
    Honjo K; Osato T; Omori S; Muraki T; Ishikawa K; Okamura N; Nakamura H
    No Shinkei Geka; 2019 May; 47(5):525-530. PubMed ID: 31105075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors and clinical features of postoperative hyperperfusion after surgical revascularization for moyamoya disease: a serial single photon emission CT/positron emission tomography study.
    Uchino H; Kuroda S; Hirata K; Shiga T; Houkin K; Tamaki N
    Stroke; 2012 Oct; 43(10):2610-6. PubMed ID: 22871684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Universal Bypass for Treatment of Symptomatic Moyamoya Disease or Moyamoya Syndrome. Analysis of a Personal Case Series on Behalf of the Italian Moyamoya Association.
    Lanterna LA; Brembilla C; Gritti P; Bernucci C
    Acta Neurochir Suppl; 2016; 123():129-32. PubMed ID: 27637639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for neurologic deterioration after revascularization surgery in patients with moyamoya disease.
    Sakamoto T; Kawaguchi M; Kurehara K; Kitaguchi K; Furuya H; Karasawa J
    Anesth Analg; 1997 Nov; 85(5):1060-5. PubMed ID: 9356100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Moyamoya syndrome associated with neurofibromatosis Type 1: perioperative and long-term outcome after surgical revascularization.
    Koss M; Scott RM; Irons MB; Smith ER; Ullrich NJ
    J Neurosurg Pediatr; 2013 Apr; 11(4):417-25. PubMed ID: 23373626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of infarction after encephaloduroarteriosynangiosis in young patients with moyamoya disease.
    Kim HG; Lee SK; Lee JD
    J Neurosurg Pediatr; 2017 Jan; 19(1):1-7. PubMed ID: 27715484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of cerebral ischemia in children with moyamoya.
    Rafay MF; Armstrong D; Dirks P; MacGregor DL; deVeber G
    Pediatr Neurol; 2015 Jan; 52(1):65-72. PubMed ID: 25459363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Surgical treatment for moyamoya disease].
    Kaminogo M; Nagata I
    No To Shinkei; 2004 Feb; 56(2):143-52. PubMed ID: 15098359
    [No Abstract]   [Full Text] [Related]  

  • 20. Unilaterally symptomatic moyamoya disease in children: long-term follow-up of 20 patients.
    Nagata S; Matsushima T; Morioka T; Matsukado K; Mihara F; Sasaki T; Fukui M
    Neurosurgery; 2006 Oct; 59(4):830-6; discussion 836-7. PubMed ID: 17038947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.